215 related articles for article (PubMed ID: 6973460)
1. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
Skopková J; Hrbas R; Barth T
Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
[TBL] [Abstract][Full Text] [Related]
2. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
3. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
Tuschy U; Meinhold J; Szeszat S
Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factors (ANF) and antidiuretic agents.
Croxatto HR; Rosas R
Acta Physiol Pharmacol Latinoam; 1988; 38(1):1-9. PubMed ID: 2974232
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
7. Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis.
Machová A
Physiol Res; 1992; 41(2):121-7. PubMed ID: 1286075
[TBL] [Abstract][Full Text] [Related]
8. The influence of a single dose of vasopressin analogs on human renal potassium excretion.
Nádvorníková H; Schück O
Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):155-8. PubMed ID: 7076344
[TBL] [Abstract][Full Text] [Related]
9. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
Vávra I; Machová A; Krejcí I
J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
[No Abstract] [Full Text] [Related]
10. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
[TBL] [Abstract][Full Text] [Related]
11. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
[TBL] [Abstract][Full Text] [Related]
12. Intraamniotic deamino(D-Arg8)-vasopressin: prolonged effects on ovine fetal urine flow and swallowing.
Kullama LK; Nijland MJ; Ervin MG; Ross MG
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):78-84. PubMed ID: 8572038
[TBL] [Abstract][Full Text] [Related]
13. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
ALI MN
Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
[TBL] [Abstract][Full Text] [Related]
14. Central administration of kisspeptin-10 inhibits water and sodium excretion of anesthetized male rats and the involvement of arginine vasopressin.
Ten SC; Gu SY; Niu YF; An XF; Yan M; He M
Endocr Res; 2010; 35(3):128-36. PubMed ID: 20712435
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
Radó JP; Borbély L
Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
[TBL] [Abstract][Full Text] [Related]
16. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
Ebenezer IS
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
[TBL] [Abstract][Full Text] [Related]
17. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
[TBL] [Abstract][Full Text] [Related]
18. A comparison between the influence of arginine-vasopressin and lysine-vasopressin on water and electrolyte excretion in ewes.
Kühn E
Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):417-25. PubMed ID: 6049335
[No Abstract] [Full Text] [Related]
19. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
Nakakura M; Terajima M; Kato Y; Hayakawa E; Ito K; Kuroda T
J Drug Target; 1995; 2(6):487-92. PubMed ID: 7773610
[TBL] [Abstract][Full Text] [Related]
20. Treatment of oligohydramnios with maternal 1-deamino-[8-D-arginine] vasopressin-induced plasma hypoosmolality.
Ross MG; Cedars L; Nijland MJ; Ogundipe A
Am J Obstet Gynecol; 1996 May; 174(5):1608-13. PubMed ID: 9065138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
